Citations 2

Drug Survival of Adalimumab and Infliximab in Hidradenitis Suppurativa

International Journal of Dermatology | May 14, 2026 | Volume: 65 | Issue: 9 | Pages: 1907-1909

10.1111/ijd.70455 | PMID 42129594

Vitamin D deficiency and systemic inflammation in hidradenitis suppurativa: clinical correlates in a retrospective cohort

British Journal of Dermatology | April 30, 2026 | Volume: 195 | Issue: 2 | Pages: 339-341

10.1093/bjd/ljag157 | PMID 42056003

Vitamin D deficiency is frequently reported in hidradenitis suppurativa (HS), but its clinical significance remains unclear. In a retrospective cohort of 503 patients, deficiency was common and associated with demographic and metabolic factors but not with treatment-defined severity. Vitamin D deficiency was independently associated with elevated C-reactive protein, suggesting a link with systemic inflammation.